# Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation

> **NCT03304431** · PHASE4 · COMPLETED · sponsor: **Abant Izzet Baysal University** · enrollment: 60 (actual)

## Conditions studied

- Cardiovascular Diseases
- Lidocaine Causing Adverse Effects in Therapeutic Use
- Tracheal Intubation Morbidity

## Interventions

- **DRUG:** Orotracheal Lidocaine Oral Spray application

## Key facts

- **NCT ID:** NCT03304431
- **Lead sponsor:** Abant Izzet Baysal University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-26
- **Primary completion:** 2017-08-20
- **Final completion:** 2017-09-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03304431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03304431, "Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03304431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*